Yousif Capital Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.36M | Sell |
34,727
-918
| -3% | -$115K | 0.05% | 362 |
|
|
2025
Q1 | $3.94M | Sell |
35,645
-1,398
| -4% | -$155K | 0.05% | 367 |
|
|
2024
Q4 | $5.06M | Sell |
37,043
-1,559
| -4% | -$213K | 0.06% | 318 |
|
|
2024
Q3 | $4.45M | Sell |
38,602
-4,903
| -11% | -$565K | 0.05% | 365 |
|
|
2024
Q2 | $5.99M | Sell |
43,505
-2,957
| -6% | -$407K | 0.07% | 273 |
|
|
2024
Q1 | $6.41M | Sell |
46,462
-346
| -0.7% | -$47.7K | 0.07% | 271 |
|
|
2023
Q4 | $6.17M | Sell |
46,808
-370
| -0.8% | -$48.8K | 0.07% | 268 |
|
|
2023
Q3 | $5.31M | Sell |
47,178
-2,555
| -5% | -$287K | 0.07% | 288 |
|
|
2023
Q2 | $4.69M | Sell |
49,733
-1,246
| -2% | -$117K | 0.06% | 336 |
|
|
2023
Q1 | $5.16M | Buy |
50,979
+180
| +0.4% | +$18.2K | 0.07% | 296 |
|
|
2022
Q4 | $6.07M | Buy |
50,799
+1,101
| +2% | +$132K | 0.08% | 245 |
|
|
2022
Q3 | $5.28M | Sell |
49,698
-4,584
| -8% | -$487K | 0.08% | 257 |
|
|
2022
Q2 | $5.29M | Buy |
54,282
+2,255
| +4% | +$220K | 0.07% | 275 |
|
|
2022
Q1 | $4.88M | Buy |
52,027
+1,657
| +3% | +$155K | 0.05% | 368 |
|
|
2021
Q4 | $4.29M | Buy |
+50,370
| New | +$4.29M | 0.04% | 462 |
|